Quantcast

Latest treatment of multiple sclerosis Stories

2009-09-10 08:18:13

The source of PML, the JC virus, is found to be reactivated in multiple sclerosis patients receiving natalizumab treatment.

2009-08-31 11:28:57

According to data supplied by the German Multiple Sclerosis Society’s national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

2009-08-25 10:49:00

CAMBRIDGE, Mass., Aug. 25 /PRNewswire/ -- Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS).

2009-07-27 16:00:00

INDIANAPOLIS and EDMONTON, Alberta, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp.

2009-07-17 16:00:00

Toronto Stock Exchange Symbol: MS EDMONTON, July 17 /PRNewswire-FirstCall/ - BioMS Medical Corp.

2009-07-13 15:46:26

Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, according to a report in the July issue of Archives of Neurology, one of the JAMA/Archives journals.

2009-05-28 07:00:00

Toronto Stock Exchange Symbol: MS EDMONTON, May 28 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr.

2009-05-11 16:30:00

Toronto Stock Exchange Symbol: MS EDMONTON, May 11 /PRNewswire-FirstCall/ - BioMS Medical Corp.

2009-04-29 07:00:00

Toronto Stock Exchange Symbol: MS EDMONTON, April 29 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr.